Medicinal chemistry and therapeutic potential of CpG DNA

被引：78

作者：

Agrawal, S ^{[1
]}

Kandimalla, ER ^{[1
]}

机构：

[1] Hybridon Inc, Cambridge, MA 02137 USA

来源：

TRENDS IN MOLECULAR MEDICINE | 2002年 / 8卷 / 03期

关键词：

D O I：

10.1016/S1471-4914(01)02264-X

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The observation that oligodeoxynucleotides containing CpG dinucleotides (CpG DNA) exhibit several immunological effects has led to their use as therapeutic agents and adjuvants for various diseases. Several CpG DNA drug candidates are currently being evaluated, either as monotherapies or as adjuvants (with vaccines, antibodies, antigens and allergens), in preclinical and clinical trials against cancers, viral and bacterial infections, allergies and asthma Knowledge gained from studies of the medicinal chemistry of CpG DNA has provided a basis for designing a second generation of CpG DNA agents with desirable cytokine-inducing and potent immunomodulatory activity. This article reviews recent progress in understanding the effects of CpG DNA, the medicinal chemistry of CpG DNA, and its possible therapeutic applications.

引用

收藏

页码：114 / 121

页数：8

相关论文

共 67 条

[1] Antisense therapeutics: is it as simple as complementary base recognition? [J].

Agrawal, S ;

Kandimalla, ER .

MOLECULAR MEDICINE TODAY, 2000, 6 (02) :72-81

[2] Antisense and/or Immunostimulatory Oligonucleotide Therapeutics [J].

Agrawal, Sudhir ;

Kandimalla, Ekambar R. .

CURRENT CANCER DRUG TARGETS, 2001, 1 (03) :197-209

[3] Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant [J].

Al-Mariri, A ;

Tibor, A ;

Mertens, P ;

De Bolle, X ;

Michel, P ;

Godefroid, J ;

Walravens, K ;

Letesson, JJ .

INFECTION AND IMMUNITY, 2001, 69 (08) :4816-4822

[4]

Banyer J L, 2000, Rev Immunogenet, V2, P359

[5] Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition [J].

Bauer, S ;

Kirschning, CJ ;

Häcker, H ;

Redecke, V ;

Hausmann, S ;

Akira, S ;

Wagner, H ;

Lipford, GB .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (16) :9237-9242

[6] Synthetic unmethylated cytosine-phosphate-guanosine oligodeoxynucleotides are potent stimulators of antileukemia responses in naive and bone marrow transplant recipients [J].

Blazar, BR ;

Krieg, AM ;

Taylor, PA .

BLOOD, 2001, 98 (04) :1217-1225

[7] IMMUNE STIMULATION BY AN ANTISENSE OLIGOMER COMPLEMENTARY TO THE REV GENE OF HIV-1 [J].

BRANDA, RF ;

MOORE, AL ;

MATHEWS, L ;

MCCORMACK, JJ ;

ZON, G .

BIOCHEMICAL PHARMACOLOGY, 1993, 45 (10) :2037-2043

[8] Enhanced dendritic cell maturation by TNF-α or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo [J].

Brunner, C ;

Seiderer, J ;

Schlamp, A ;

Bidlingmaier, M ;

Eigler, A ;

Haimerl, W ;

Lehr, HA ;

Krieg, AM ;

Hartmann, G ;

Endres, S .

JOURNAL OF IMMUNOLOGY, 2000, 165 (11) :6278-6286

[9] Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P) [J].

Cafaro, A ;

Titti, F ;

Fracasso, C ;

Maggiorella, MT ;

Baroncelli, S ;

Caputo, A ;

Goletti, D ;

Borsetti, A ;

Pace, M ;

Fanales-Belasio, E ;

Ridolfi, B ;

Negri, DRM ;

Sernicola, L ;

Belli, R ;

Corrias, F ;

Macchia, I ;

Leone, P ;

Michelini, Z ;

ten Haaft, P ;

Buttò, S ;

Verani, P ;

Ensoli, B .

VACCINE, 2001, 19 (20-22) :2862-2877

[10]

Carpentier AF, 2000, CLIN CANCER RES, V6, P2469

← 1 2 3 4 5 6 7 →